REQUEST A DEMO
Total
USD $0.00
Search more companies

Blirt S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Blirt S.A. Profile Updated: August 25, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

BLIRT S.A., a biotechnology company, focuses on the production of specialty enzymes utilized in nucleic acid purification and sequencing in Poland. The company offers a suite of services, including the design of commercially applicable expression systems, upstream and downstream protein production method development in yeast, and bacterial hosts. It protein products comprise proteinases, RNase inhibitors, reverse transciptases, polymerases, ligases, and other proteins; and native and recombinant proteins expression systems.

Headquarters
Ul. Trzy Lipy 3/1.38
Gdansk; Pomorskie; Postal Code: 80172

Contact Details: Purchase the Blirt S.A. report to view the information.

Website: http://www.blirt.eu

Basic Information
Total Employees:
Purchase the Blirt S.A. report to view the information.
Outstanding Shares:
Purchase the Blirt S.A. report to view the information.
Registered Capital:
Purchase the Blirt S.A. report to view the information.
Financial Auditors:
Purchase the Blirt S.A. report to view the information.
Incorporation Date:
September 10, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Blirt S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-22.3%
Total operating revenue
-20.1%
Operating profit (EBIT)
-89.3%
EBITDA
-70.21%
Net Profit (Loss) for the Period
-93.67%
Total assets
35.57%
Total equity
1.8%
Operating Profit Margin (ROS)
-20.62%
Net Profit Margin
-15.73%
Return on Equity (ROE)
-26.75%
Debt to Equity Ratio
-0.4%
Quick Ratio
-1.41%
Cash Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?